News for Edwards Lifesciences Corporation (EW)

Edwards Lifesciences is slated to unveil its second-quarter earnings this month, and analysts are projecting a double-digit decrease in earnings.

We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on DIY Investor’s Substack. In this article, we will summarize the bulls’ thesis on EW.

We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on DIY Investor’s Substack. In this article, we will summarize the bulls’ thesis on EW. Edwards Lifesciences Corporation (EW)’s share was trading at $75.8 as of 10th June. EW’s trailing and forward P/E were 31.55 and 31.25 respectively according to Yahoo Finance. Edwards Lifesciences (EW) is […]

Edwards Lifesciences, a leader in heart medical devices, has shown strong growth, innovation, and attractive valuation. Read more on what makes EW a BUY.

Edwards Lifesciences is projected to deliver steady profit and revenue growth through 2026. Click here to read more on EW stock prospects.

Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial a

We recently published a list of Jim Cramer’s Recent Thoughts on These 15 Stocks. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other stocks that Jim Cramer discussed recently. On Monday, Mad Money host Jim Cramer addressed the market’s reaction to the recent U.S. debt […]

**media[630001,630002]**

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs […]

Edwards Lifesciences Corporation (EW), a leading medical technology company, has announced the approval of significant amendments to its Employee Stock Purcha

Edwards Lifesciences (NYSE: EW) today announced it will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Bernard Zovig

Looking into the current session, Edwards Lifesciences Inc. EW shares are trading at $75.58, after a 0.12% increase. Moreover, over the past month, the stock in...

Edwards Lifesciences (NYSE: EW) announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR)

Edwards Lifesciences (EW) secures FDA approval for its SAPIEN 3 TAVR platform for asymptomatic severe aortic stenosis patients. The approval is based on

PR NewswireFRANKLIN LAKES, N.J., May 1, 2025 Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organicGAAP and adjusted di

We recently published a list of How Did Jim Cramer’s 12 Bold Predictions Play Out?. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other stocks that Jim Cramer recently discussed. During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in […]

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Mar. 31, 2025. Recent Highlights Q1 sales grew 6.2% to $1.41 billion,

Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA

\nEdwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2025 after the market closes on Wednesday April 23, 202